Perella Weinberg Partners (PWP) Stock Analysis

Verdict: AVOID

Termination of PIPR merger talks and negative equity offset consensus M&A recovery expectations — near-term execution risk remains elevated.

Investment score: 38/100

Analysis as of

Is Perella Weinberg Partners stock worth reviewing? The TradeMates thesis

The TradeMates model recommends AVOIDING PWP. Broken merger negotiations with Piper Sandler, a negative equity balance sheet (-$127.4M), insider selling, and an elevated TTM P/E of 41.88x present significant near-term downside risks.

7-factor investment score

Perella Weinberg Partners opportunities and risks

What speaks for PWP

What speaks against PWP

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
PWP41.9x2.2x34.6x124.8%3.2%5.9%
BULL73.4x5.0x40.2x77.5%6.3%0.0%
SECZn/a54.3xn/a17.1%-91.3%-0.5%
LCLN2424.0x2.2x43.9x36.9%-5.5%11.9%
BGC27.8x1.6x12.5x80.0%5.9%7.1%
OPY10.5x0.6x7.2x80.2%5.7%-2.1%
Peer median27.8x2.2x12.5x77.5%5.7%0.0%

Frequently asked questions about Perella Weinberg Partners (PWP)

Is PWP stock a good investment?

The TradeMates model rates Perella Weinberg Partners as AVOID with an investment score of 38/100. The TradeMates model recommends AVOIDING PWP. Broken merger negotiations with Piper Sandler, a negative equity balance sheet (-$127.4M), insider selling, and an elevated TTM P/E of 41.88x present significant near-term downside risks. This is algorithmic model output, not personal investment advice.

Is PWP stock a buy?

The TradeMates model verdict for PWP is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.